BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang JB, Chen NC, Chen CL, Fu MH, Pan HY, Hsu CY, Chen SD, Chuang YC. Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 Associated with the Severity and Outcome of Acute Ischemic Stroke. J Clin Med 2020;10:E61. [PMID: 33375339 DOI: 10.3390/jcm10010061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Li F, Yang T, Li H, Liu T, Wang Y, Xu M, Yan L, Zhang Y, Wang Y, Fu L, Geng D. Increased serum interleukin-34 levels as a novel diagnostic and prognostic biomarker in patients with acute ischemic stroke. J Neuroimmunol 2021;358:577652. [PMID: 34217885 DOI: 10.1016/j.jneuroim.2021.577652] [Reference Citation Analysis]
2 Backes FN, de Souza A, Bianchin MM. Biomarkers in the prognostic evaluation of ischemic stroke: Is there benefit in the measurements of TREM-1 and TREM-2 in the acute phase? Clin Biochem 2021:S0009-9120(21)00205-8. [PMID: 34339680 DOI: 10.1016/j.clinbiochem.2021.07.016] [Reference Citation Analysis]
3 Wang J, Yao J, Liu Y, Huang L. Targeting the gasdermin D as a strategy for ischemic stroke therapy. Biochem Pharmacol 2021;188:114585. [PMID: 33930348 DOI: 10.1016/j.bcp.2021.114585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gu Y, Deng X, Liang C, Chen Y, Lei H, Zhang Q. Soluble triggering receptor expressed on myeloid cells-1 as a serum biomarker of early neurologic deterioration and prognosis in acute supratentorial intracerebral hemorrhage. Clin Chim Acta 2021;523:290-6. [PMID: 34655609 DOI: 10.1016/j.cca.2021.10.010] [Reference Citation Analysis]